DK1301537T3 - Peptider og anvendelse deraf i assays til kardiovaskulær sygdom - Google Patents

Peptider og anvendelse deraf i assays til kardiovaskulær sygdom

Info

Publication number
DK1301537T3
DK1301537T3 DK01949734T DK01949734T DK1301537T3 DK 1301537 T3 DK1301537 T3 DK 1301537T3 DK 01949734 T DK01949734 T DK 01949734T DK 01949734 T DK01949734 T DK 01949734T DK 1301537 T3 DK1301537 T3 DK 1301537T3
Authority
DK
Denmark
Prior art keywords
assays
peptides
cardiovascular disease
cyclised
affinity
Prior art date
Application number
DK01949734T
Other languages
Danish (da)
English (en)
Inventor
Outi Narvanen
Seppo Yla-Herttuala
Original Assignee
Ark Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Oy filed Critical Ark Therapeutics Oy
Application granted granted Critical
Publication of DK1301537T3 publication Critical patent/DK1301537T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01949734T 2000-07-18 2001-07-18 Peptider og anvendelse deraf i assays til kardiovaskulær sygdom DK1301537T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use
PCT/GB2001/003212 WO2002006314A2 (fr) 2000-07-18 2001-07-18 Utilisation de peptides dans des dosages pour maladie cardio-vasculaire

Publications (1)

Publication Number Publication Date
DK1301537T3 true DK1301537T3 (da) 2008-12-08

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01949734T DK1301537T3 (da) 2000-07-18 2001-07-18 Peptider og anvendelse deraf i assays til kardiovaskulær sygdom

Country Status (12)

Country Link
US (2) US20040091934A1 (fr)
EP (1) EP1301537B1 (fr)
JP (1) JP2004504327A (fr)
AT (1) ATE408626T1 (fr)
AU (1) AU2001270851A1 (fr)
CA (1) CA2417789A1 (fr)
DE (1) DE60135846D1 (fr)
DK (1) DK1301537T3 (fr)
ES (1) ES2312455T3 (fr)
GB (1) GB0017641D0 (fr)
PT (1) PT1301537E (fr)
WO (1) WO2002006314A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
PL372925A1 (en) 2001-09-28 2005-08-08 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug
WO2005097206A2 (fr) 2004-04-06 2005-10-20 Cedars-Sinai Medical Center Prevention et traitement des maladies vasculaires avec des vecteurs de virus associes aux adenovirus de recombinaison codant l'apolipoproteine a-i et l'apolipoproteine a-i milano
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
CA2667012A1 (fr) * 2006-10-26 2008-05-02 Abbott Laboratories Analyse immunologique d'analytes dans des echantillons contenant des anticorps anti-analytes endogenes
EP2115466A4 (fr) * 2006-12-22 2010-07-28 Abbott Lab Panel de maladies auto-immunes cardiovasculaires et methodes d'utilisation correspondantes
WO2012074725A2 (fr) 2010-11-12 2012-06-07 Cedars-Sinai Medical Center Procédés et systèmes immunomodulateurs pour le traitement et/ou la prévention de l'hypertension
CN103501806A (zh) 2010-11-12 2014-01-08 赛达斯西奈医疗中心 用于治疗和/或预防动脉瘤的免疫调节方法和系统
JP5857312B2 (ja) * 2011-08-11 2016-02-10 積水メディカル株式会社 心疾患診断マーカー
CN107085025B (zh) * 2016-02-15 2019-09-17 太原师范学院 一种自组装三层膜电极及其制备方法和用途
EP3463416A1 (fr) 2016-05-31 2019-04-10 CardioVax, LLC Procédés de diagnostic et de traitement du lupus érythémateux disséminé
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN111855986A (zh) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 联合定量检测五项心脏标志物试剂盒及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
EP1021728B8 (fr) * 1997-06-20 2008-04-23 Leuven Research & Development VZW Dosages, anticorps et etalons de detection de lipoproteines de basse densite, oxydees et modifiees par mda

Also Published As

Publication number Publication date
AU2001270851A1 (en) 2002-01-30
DE60135846D1 (de) 2008-10-30
PT1301537E (pt) 2008-12-04
CA2417789A1 (fr) 2002-01-24
WO2002006314A2 (fr) 2002-01-24
US20040091934A1 (en) 2004-05-13
EP1301537A2 (fr) 2003-04-16
JP2004504327A (ja) 2004-02-12
ATE408626T1 (de) 2008-10-15
ES2312455T3 (es) 2009-03-01
EP1301537B1 (fr) 2008-09-17
GB0017641D0 (en) 2000-09-06
WO2002006314A3 (fr) 2002-04-18
US20080261234A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
DK1301537T3 (da) Peptider og anvendelse deraf i assays til kardiovaskulær sygdom
DE60144145D1 (de) Subtilisin-variante
ATE498011T1 (de) Modifizierte embryonale stammzellen und embryonales stammzellspezifisches gen
GB9812523D0 (en) Peptide inhibitors of hepatitis c virus ns3 protease
ATE279203T1 (de) Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
KR880701728A (ko) 조직-형 및 우로키나제-형 플라스 미노겐 활성체 억제제의 진단검정 방법 및 억제제의 암호화 유전자
DK0935609T3 (da) Krystalliserbare præparater omfattende et hepatitis-C-virus-NS3-proteasedomæne/NS4A-kompleks og dermed opnåede krystaller
DK1558730T3 (da) Inhibitorresistent HCV-NS3-protease
NO20052992D0 (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
WO2002030959A3 (fr) Peptides derives de smac (diablo) et procedes d'utilisation de ceux-ci
WO2001075157A1 (fr) Sonde servant a fabriquer un polymere sonde, procede de fabrication d'un polymere sonde et son utilisation
Oyama et al. Purification and characterization of a thrombin like enzyme, elegaxobin II, with lys-bradykinin releasing activity from the venom of Trimeresurus elegans (Sakishima-Habu)
ATE374838T1 (de) Nukleotidsequenzvariation im gen ns5a als marker
DE69633231D1 (de) Tnf-alpha konvertierendes enzym
DE60027030D1 (de) Membrantranslokierendes peptid als wirkstofftransportsystem
DE69831229D1 (de) Schnelle bestimmung des verhältnisses von biologischen molekülen
ATE369442T1 (de) In vitro evolution von nukleinsäuren und kodierten polypeptiden
DE69913325D1 (de) Nephrin gen und protein
Desmazes et al. Kininogen‐derived peptides for investigating the putative vasoactive properties of human cathepsins K and L
WO2001006019A3 (fr) Acides nucleiques servant a detecter des parvovirus et procedes d'utilisation de ceux-ci
ATE389029T1 (de) Protease assay zur kontrolle medikamentöser therapie
ATE510922T1 (de) Induzierbare promotoren
Nakagomi et al. Isolation of cathepsin B inhibitory peptides, Cabin-A1 and-A2, from a tryptic and chymotryptic hydrolysate of human serum albumin